// App-Quantinova.ai

2127 : Tumor Necrosis Factor Inhibitors for Sarcoidosis

Researchers

Presenter

  • Stefanie Wade

Principal Investigators

  • N/A

Medical Centers

  • Mollie Carruthers

  • University of Connecticut Health Center, Farmington, CT

  • Division of Hematology, University of British Columbia, Vancouver, BC, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • N/A

Biomarkers

  • Tumor necrosis factor

  • Interferon

Drug/Treatment

  • Certolizumab pegol

  • Adalimumab

  • Infliximab

  • Etanercept

  • CHS-0214

  • golimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved